Genetic variability in N-acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil

Leukemia and Lymphoma

Volumn 53, Issue 2, 2012, Pages 323-327

  Zanrosso, Crisiane Wais ^a,b   Emerenciano, Mariana ^a   Faro, Alessandra ^a   De Aguiar Gonçalves, Bruno Alves ^a   Mansur, Marcela Braga ^a   Pombo De Oliveira, Maria S ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; NAT2; Polymorphisms

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BRAZIL; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ARYLAMINE N-ACETYLTRANSFERASE; BRAZIL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84856091220     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.619605     Document Type: Article

References (20)

1. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252-257. (Pubitemid 38029946)
2. Pombo-de-Oliveira MS, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol. Biomarkers Prev 2006;15:2336-2341. (Pubitemid 46048287)
3. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev 2000;9:29-42. (Pubitemid 30062907)
4. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-659. (Pubitemid 41176017)
5. Jiao L, Doll MA, Hein DW, et al. Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2379-2386. (Pubitemid 351196371)
6. Lemos MC, Cabrita FJ, Silva HA, et al. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 1999;20:1225-1229. (Pubitemid 29341442)
7. Majumdar S, Mondal BC, Ghosh M, et al. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 2008;17:125-132. (Pubitemid 351301623)
8. Krajinovic M, Richer C, Sinnett H, et al. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000;9:557-562. (Pubitemid 30396176)
9. Zanrosso CW, Emerenciano M, Goncalves BA, et al. N-acetyltransferase 2 polymorphisms and susceptibility to infant leukemia with maternal exposure to dipyrone during pregnancy. Cancer Epidemiol Biomarkers Prev 2010;19:3037-3043.
10. de Souza Reis R Sr, de Camargo B, de Oliveira Santos M, et al. Childhood leukemia incidence in Brazil according to different geographical regions. Pediatr Blood Cancer 2011;56:58-64.
11. Parra FC, Amado RC, Lambertucci JR, et al. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003;100:177-182. (Pubitemid 36078048)
12. Cascorbi I, Brockmoller J, Mrozikiewicz PM, et al. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996;56:3961-3966. (Pubitemid 26284745)
13. Hein DW, Boukouvala S, Grant DM, et al. Changes in consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenet Genomics 2008;18:367-368. (Pubitemid 351367530)
14. Vatsis KP, Weber WW, Bell DA, et al. Nomenclature for N-acetyltransferases. Pharmacogenetics 1995;5:1-17.
15. Possuelo LG, Castelan JA, de Brito TC, et al. Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. Eur J Clin Pharmacol 2008;64:673-681.
16. Teixeira RL, Miranda AB, Pacheco AG, et al. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil. Mutat Res 2007;624:31-40. (Pubitemid 47595332)
17. Bailliet G, Santos MR, Alfaro EL, et al. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay. Mutat Res 2007;627:171-177. (Pubitemid 46097495)
18. Rollinson S, Roddam P, Willett E, et al. NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a casecontrol study. Cancer Epidemiol Biomarkers Prev 2001;10:567-568. (Pubitemid 32701647)
19. Perera FP, Jedrychowski W, Rauh V, et al. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 1999;107:451-460. (Pubitemid 29346991)
20. Greaves M. Childhood leukaemia. BMJ 2002;324:283- 287.